Investor Ideas #Potcasts 632, #Cannabis News and #Stocks on the Move- Interview with CEO of Flora Growth Corp. (NASDAQ: $FLGC)
Delta, Kelowna, BC, June 1, 2022 (Investorideas.com Newswire), investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site release today’s podcast edition of cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
https://www.investorideas.com/Audio/Podcasts/2022/060122-Cannabis-FLGC.mp3
Read this in full
at https://www.investorideas.com/news/2022/cannabis-potcasts/06011Interview-Flora-Growth-Corp.asp
Hear Investor ideas cannabis potcast on iTunes
Hear the investor ideas potcast on Spotify
Today’s podcast overview/transcript:
In today’s podcast,
Investorideas interviews Luis Merchan,
CEO of Flora Growth Corp. (NASDAQ:FLGC), where we discussed the company’s
last few months of business, the CBD market coming out of Colombia as well as
the CBD industry over all and what is on the horizon for Flora Growth Corp.
moving forward.
Speaking on the
last few months of Flora Growth’s business development, specifically their
acquisition and development of JustCBD,, Merchan commented, “It seems like
every month is a meaningful month in terms of progress and execution of our
strategy. Starting with the acquisition of JustCBD, which is a leading brand in
the CBD space in the United States, which is the most sought after market in
the entire world. We expect sales of CBD to triple over the next five years as
adoption continues to rise and there are a number of categories that are
leading the pace when it comes to growth and JustCBD plays in all of them.
Flora Growth Corp. recently announced that JustCBD will be
launching its line of Novel Foods registered CBD products on Amazon.co.uk.
Amazon UK entered the now £700
million CBD market in October 2021 and has since expanded the initial
pilot-only program to include vendors who have demonstrated their compliance
with the UK CBD Novel Food regulations. Producers awarded with UK Novel Food
authorization must prove the product is safe for consumption and labeled
correctly.
"With health and wellness
playing an increasingly important role in customers’ lives, we are excited to
increase the selection of quality CBD products offered to Amazon customers in
the UK," said Hussein Rakine, CEO of JustCBD. "The JustCBD team looks
forward to working closely with Amazon to expand our product offering to other
countries as our partnership and brand presence in the United Kingdom
grows."
JustCBD’s product line is expected
to launch on Amazon.co.uk in June of 2022 and will make available a portfolio
of JustCBD’s best-selling gummies and tinctures.
"International growth is a key
objective of our company’s strategy. The launch on Amazon UK allows Flora to
reach a larger consumer base in search of quality CBD products," said Luis
Merchan, CEO of Flora Growth. "We are excited to continue expanding our
operations in Europe and to deliver top-quality cannabis-related products to
customers aiming to improve their health and wellness."
The JustCBD acquisition was timed
with changes in Colombia as Merchan mentioned, “Colombia has had some
meaningful changes, starting with Resolution 227, which basically
immediately allowed our strategy to come into play out of Colombia with the
manufacturing, production and export of CBD infused products. Immediately after
that resolution was completed we proceeded to complete our first export of
products.”
Speaking on how Colombia will fit
into the global cannabis industry, Mechan commented, “Our hypothesis early on,
several years ago when we were founding the company was, that Colombia would
become the Green BreadBasket of the World. The first growth pillar of Flora, is
without a doubt, the Plant. We are going to have the opportunity over the next
few months to have the opportunity to start exporting dry flower and exporting
some of these finished products to a number of countries around the world while
generating a significant of economic benefit to the Colombian population which
has been frankly decimated over the last few decades wit the war on drugs. The
single greatest advantage that you have with being in Colombia, is you are able
to take advantage of all the knowhow, the agricultural knowhow, the fact that
Colombia is on the equator, and grow a high quality product at one of the
lowest production costs in the world. Now with the changes in the regulatory
environment, Colombia will be at the vanguard of cannabis distribution and
Flora will be leading the charge.”
Flora Growth Corp. also recently announced that the Company has
formally begun the integration of its licensed and Control Union Medical
Cannabis Standard GACP ("CUMCS-GACP") certified cannabis products and
derivatives into its global roster of branded products. Beginning with CBD
derivatives used in its award-winning skincare brand, Mind Naturals, the
Company has begun the process of integrating significantly lower-cost
cannabinoids, grown and extracted at Flora’s cultivation and extraction
facility, Cosechemos, for products formulated at the Company’s GMP-licensed
laboratory in Bogota, Colombia.
This event marks a milestone in
Flora’s integration strategy, allowing Flora to further its global supply chain
efficiencies and independence while bolstering its competitive advantage in
white label and wholesale businesses.
"The key to unlocking the
potential of the global cannabis market is supply chain mastery - this is our
focus," Flora CEO Luis Merchan said. "Connecting our high-quality
derivatives with our significant portfolio of revenue-producing global brands
is a significant step in maximizing compounded value creation from seed to
shelf."
Flora shows little sign of slowing
down having also announced that it has entered into
an agreement with leading cell biologist, Dr. Annabelle Manalo-Morgan, Ph.D.,
to acquire her brand Masaya, together with its patent-pending CBD formulations.
Created by Dr. Annabelle and backed by her research, Masaya’s formulations of
pure, potent CBD oil are 100% THC-free and have a long track record of positive
testimonials collected over years of use. Flora intends to distribute the brand
and its formulations worldwide.
Masaya will become an owned Flora
brand sold in the US and will be the first offering from Flora Life Sciences.
In addition, it is expected that the original patent-pending formulation,
Masaya Pure, will be used in Flora’s current clinical trials with the
University of Manchester in the UK. The formulation is also in the process of
being registered with the Colombian regulatory agency, INVIMA, as one of the
first distribution steps beyond the US.
Merchan went on to discuss some of
the difficulties of importing/exporting CBD and cannabis products, how Flora
has helped separate themselves from their local Colombian competition as well
as what he expects for Flora moving forward.
To find out more information
regarding Flora Growth Corp. visit their website here.
Investor ideas reminds all
listeners to read our disclaimers and disclosures on the Investorideas.com
website and that this podcast is not an endorsement to buy products or services
or securities. Investors are reminded all investment involves risk and possible
loss of investment.
To hear more
Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
The
Investorideas.com podcasts are also available on iTunes ( Apple Podcasts)
, Audible , Spotify, Tunein, Stitcher,
Spreaker.com, iHeartRadio , Google
Podcasts and most audio platforms available.
About Investorideas.com - News that Inspires Big
Investing Ideas
Investorideas.com
publishes breaking stock news, third party stock research , guest posts and
original articles and podcasts in
leading stock sectors. Learn about
investing in stocks and get investor
ideas in cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable
energy, gaming and more. Investor Idea’s original branded content includes
podcasts and columns : Crypto Corner , Play
by Play sports and stock news , Investor Ideas Potcasts
Cannabis News and Stocks on the Move podcast ,
Cleantech
and Climate Change , Exploring
Mining , Betting
on Gaming Stocks Podcast and the AI
Eye Podcast.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news,
articles and equity research as well as creates original content, including
video, interviews and articles. Original content created by investorideas is
protected by copyright laws other than syndication rights. Our site does not
make recommendations for purchases or sale of stocks, services or products.
Nothing on our sites should be construed as an offer or solicitation to buy or
sell products or securities. All investing involves risk and possible losses.
This site is currently compensated for news publication and distribution, social
media and marketing, content creation and more. Disclosure is posted for each
compensated news release, content published /created if required but otherwise
the news was not compensated for and was published for the sole interest of our
readers and followers. Contact management and IR of each company directly
regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our
other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com Global investors must adhere to regulations of
each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where
permissible by law. Our site does not possess, distribute, or sell cannabis
products.
Follow us on Twitter https://twitter.com/Investorideas
Follow
us on Facebook https://www.facebook.com/Investorideas
Follow
us on YouTube https://www.youtube.com/c/Investorideas
Contact Investorideas.com
800
665 0411
Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory